New Directions In STD Treatment - University of Hawaii
New Directions In STD Treatment - University of Hawaii New Directions In STD Treatment - University of Hawaii
Chlamydia and Gonorrhea Expedited Partner Treatment � Expedited Partner Treatment (EPT) or Patient- Delivered Partner Treatment (PDPT) �Option for partner management for heterosexual men and women � Written materials should accompany medication and specially mention concern about PID in female partners �First line management is clinical evaluation �Not recommended in MSM because of concern regarding co-morbidities (e.g., HIV and other STDs) �CDC has developed separate guidance on EPT/PDPT
Provider Barriers to PDPT, CA 2002 Incomplete care for partner* Dangerous without knowing hx* Practice not paid for May get me sued* Partners name must be provided Only for male partners *Significant predictors of no PDPT MD* NP 0 20 40 60 80 100 Strongly agree/agree (%) Data source: CA DHS STD Control Branch California Provider Survey
- Page 1 and 2: New Directions in STD Treatment: Hi
- Page 3 and 4: CDC 2006 STD Treatment Guidelines D
- Page 5 and 6: Challenging Management Dilemmas in
- Page 7 and 8: Sexual History Taking: The 5 P’s
- Page 9 and 10: Recommend Nucleic Acid Amplificatio
- Page 11 and 12: Percent Screened Estimated Chlamydi
- Page 13 and 14: STD Screening for MSM STD Site Type
- Page 15 and 16: Prevalence of rectal chlamydia and
- Page 17 and 18: Prevalence of pharyngeal chlamydia
- Page 19 and 20: C. trachomatis NAAT Testing …not
- Page 21 and 22: Chlamydia Treatment in Pregnancy Re
- Page 23: Percent 16 14 12 10 Infection Durin
- Page 27 and 28: Gonorrhea Screening in Females �
- Page 29 and 30: Percent of Neisseria gonorrhoeae Is
- Page 31 and 32: Gonorrhea Treatment of Urogenital I
- Page 33 and 34: Lymphogranuloma Venereum (LGV) C. t
- Page 35 and 36: LGV Proctocolitis: Serologic Diagno
- Page 37 and 38: Phil and the Penis on the Go
- Page 39 and 40: The Three “R”s of Syphilis �
- Page 41 and 42: Latent Syphilis � No clinical man
- Page 43 and 44: Syphilis EIA Tests �Treponemal te
- Page 45 and 46: Criteria for CSF Examination � Ne
- Page 47 and 48: Syphilis Resistant to Azithromycin!
- Page 51 and 52: HSV Issues � Role of type-specifi
- Page 53 and 54: Rates of Transmission of HSV-2 to S
- Page 55 and 56: Genital Herpes - Treatment Issues
- Page 57 and 58: HPV Issues � Clarify uses of HPV
- Page 59 and 60: Issues Regarding Anal Cancer Screen
- Page 61 and 62: Cervicitis - Diagnostic Issues �
- Page 63 and 64: Pelvic Inflammatory Disease Issues
- Page 65 and 66: PID: Oral Treatment Regimens Oral r
- Page 67 and 68: Vaginitis Trichomonas Bacterial Vag
- Page 69 and 70: Tinidazole: A New Treatment Option
- Page 71 and 72: Proposed Management Trichomoniasis
- Page 73 and 74: BV Treatment Recommended regimens:
Chlamydia and Gonorrhea Expedited<br />
Partner <strong>Treatment</strong><br />
� Expedited Partner <strong>Treatment</strong> (EPT) or Patient-<br />
Delivered Partner <strong>Treatment</strong> (PDPT)<br />
�Option for partner management for heterosexual<br />
men and women<br />
� Written materials should accompany medication and<br />
specially mention concern about PID in female<br />
partners<br />
�First line management is clinical evaluation<br />
�Not recommended in MSM because <strong>of</strong> concern<br />
regarding co-morbidities (e.g., HIV and other<br />
<strong>STD</strong>s)<br />
�CDC has developed separate guidance on<br />
EPT/PDPT
Change language